Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Apr 30;27(2):279–291. doi: 10.5056/jnm20205

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Korean Society of Neurogastroenterology and Motility

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Effect of the trial on total microbiota composition (n = 98) measured with (A) principal coordinate analysis based on the distance matrix of Bray-Curtis dissimilarity shows a statistical difference between the samples at baseline (BL) and after 12 weeks on mesalazine (MZ) treatment whereas the placebo (PL) group was not significantly different from BL, the colored circles represent 50% of the data. (B) There was a significant increase in microbial richness in the PL group but not MZ group after 12 weeks (*P = 0.011).